Patents by Inventor Rachael Buck

Rachael Buck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220249527
    Abstract: Disclosed are methods of reducing the incidence of oxidative stress in infants, toddlers, and children using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective at reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: April 25, 2022
    Publication date: August 11, 2022
    Applicant: ABBOTT LABORATORIES
    Inventors: Steven R. DAVIS, Rachael BUCK, Geralyn O. DUSKA-MCEWEN
  • Patent number: 11337990
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to individuals including preterm infants, infants, toddlers, and children for improving gastrointestinal function and tolerance, as well as the growth of beneficial bacteria. Additional suitable methods of using the nutritional compositions including the human milk oligosaccharides are also disclosed.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: May 24, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, JoMay Chow, Steven R. Davis
  • Patent number: 11311562
    Abstract: Disclosed are methods of reducing the incidence of oxidative stress in infants, toddlers, and children using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective at reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: October 23, 2017
    Date of Patent: April 26, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen
  • Publication number: 20220117984
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for improving airway defense mechanisms.
    Type: Application
    Filed: December 27, 2021
    Publication date: April 21, 2022
    Applicant: ABBOTT LABORATORIES
    Inventors: RACHAEL BUCK, GERALYN O. DUSKA-MCEWEN, STEVEN R. DAVIS
  • Patent number: 11260088
    Abstract: Disclosed are nutritional compositions including 2?-fucosyllactose (2?-FL) in combination with lutein and RRR-alpha-tocopherol. The nutritional compositions are useful for improving at least one of gut function, health, and development in an individual. In certain embodiments, the nutritional compositions can improve growth or maturation of the gut, as well as promote a healthy balance of beneficial bacteria in the gastrointestinal tract thereby treating and/or preventing formula intolerance or other gastrointestinal diseases and/or disorders resulting from suboptimal gastrointestinal flora population/balance.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: March 1, 2022
    Assignee: ABBOTT LABORATORIES
    Inventors: Alejandro Perez Barranco, Maria Gonzalez Ramirez, Rachael Buck, Enrique Hernandez Vazquez
  • Publication number: 20210401862
    Abstract: Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.
    Type: Application
    Filed: September 13, 2021
    Publication date: December 30, 2021
    Applicant: ABBOTT LABORATORIES
    Inventors: ENRIQUE VAZQUEZ HERNANDEZ, RICARDO RUEDA CABRERA, RACHAEL BUCK, MARIA RAMIREZ GONZALEZ
  • Patent number: 11207335
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for improving airway defense mechanisms.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: December 28, 2021
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Geralyn O. Duska-McEwen, Steven R. Davis
  • Patent number: 11197875
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: December 14, 2021
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Geralyn O. Duska-McEwen, Joseph P. Schaller
  • Patent number: 11179406
    Abstract: Disclosed are methods of reducing the incidence of necrotizing enterocolitis in an infant, toddler, or child using nutritional compositions including human milk oligosaccharides. The nutritional compositions including the human milk oligosaccharides are effective in reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: November 11, 2019
    Date of Patent: November 23, 2021
    Assignee: ABBOTT LABORATORIES
    Inventors: JoMay Chow, Steven R. Davis, Rachael Buck, Geralyn O. Duska-McEwen, Hawley K. Linke
  • Patent number: 11135233
    Abstract: A method for preventing or mitigating an acute allergic response in a subject is disclosed. The method includes a step of administering a nutritional composition to the subject. The nutritional composition includes at least one of an acidic or a neutral HMO, but does not include an N-acetyl-lactosamine.
    Type: Grant
    Filed: December 30, 2019
    Date of Patent: October 5, 2021
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Steven Davis, Paul Forsythe
  • Patent number: 11116779
    Abstract: Disclosed are methods of modulating and/or decreasing serum corticosterone levels in an individual affected by stress. Further disclosed are methods of modulating the hypothalamic pituitary adrenal response in an individual. The methods include administration of 2-fucosyl-lactose to an individual.
    Type: Grant
    Filed: August 30, 2019
    Date of Patent: September 14, 2021
    Assignee: ABBOTT LABORATORIES
    Inventors: Enrique Vazquez Hernandez, Ricardo Rueda Cabrera, Rachael Buck, Maria Ramirez Gonzalez
  • Publication number: 20210228603
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: April 12, 2021
    Publication date: July 29, 2021
    Applicant: ABBOTT LABORATORIES
    Inventors: RACHAEL BUCK, GERALYN O. DUSKA-MCEWEN, JOSEPH P. SCHALLER
  • Publication number: 20210113630
    Abstract: Disclosed are nutritional compositions including 2?-fucosyllactose (2?-FL) in combination with lutein and RRR-alpha-tocopherol. The nutritional compositions are useful for improving at least one of gut function, health, and development in an individual. In certain embodiments, the nutritional compositions can improve growth or maturation of the gut, as well as promote a healthy balance of beneficial bacteria in the gastrointestinal tract thereby treating and/or preventing formula intolerance or other gastrointestinal diseases and/or disorders resulting from suboptimal gastrointestinal flora population/balance.
    Type: Application
    Filed: June 21, 2018
    Publication date: April 22, 2021
    Applicant: ABBOTT LABORATORIES
    Inventors: Alejandro Perez BARRANCO, Maria Gonzalez RAMIREZ, Rachael BUCK, Enrique Hernandez VAZQUEZ
  • Patent number: 10973837
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: April 13, 2021
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Geralyn O. Duska-McEwen, Joseph P. Schaller
  • Publication number: 20210077512
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides in combination with long chain polyunsaturated fatty acids and/or carotenoids that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: November 16, 2020
    Publication date: March 18, 2021
    Applicant: ABBOTT LABORATORIES
    Inventors: RACHAEL BUCK, GERALYN O. DUSKA-MCEWEN, JOSEPH P. SCHALLER
  • Publication number: 20210038620
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: October 23, 2020
    Publication date: February 11, 2021
    Applicant: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Debra Thomas, Joseph Schaller
  • Publication number: 20200338103
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Application
    Filed: July 13, 2020
    Publication date: October 29, 2020
    Applicant: Abbott Laboratories
    Inventors: Rachael Buck, Geralyn O. Duska-McEwen, Joseph P. Schaller
  • Patent number: 10813940
    Abstract: Disclosed are nutritional compositions including human milk oligosaccharides and nucleotides that can be administered to preterm infants, term infants, toddlers, and children for reducing inflammation and the incidence of inflammatory diseases.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: October 27, 2020
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Debra Thomas, Joseph Schaller
  • Patent number: 10792294
    Abstract: A method for enhancing an individual's mucosal innate immune response to pathogens is disclosed. The method includes a step of administering a nutritional composition to the individual. The nutritional composition includes about 0.05 to about 0.5 mg/mL 2?-fucosyllactose (2?-FL), about 0.05 to about 0.5 mg/mL lacto-N-neotetraose (LNnT), or a combination of both. Also disclosed is a method for enhancing an individual's mucosal innate immune detection of pathogens. The method includes a step of administering a nutritional composition to the individual. The nutritional composition includes a neutral human milk oligosaccharide.
    Type: Grant
    Filed: April 3, 2015
    Date of Patent: October 6, 2020
    Assignee: ABBOTT LABORATORIES
    Inventors: Rachael Buck, Geralyn Duska-McEwen, Steven Davis
  • Publication number: 20200230162
    Abstract: Disclosed is a nutritional composition for use in modulating or reducing inflammation in an adult or elderly individual in need thereof. In some aspects, the nutritional composition comprises a neutral human milk oligosaccharide.
    Type: Application
    Filed: April 2, 2020
    Publication date: July 23, 2020
    Applicant: ABBOTT LABORATORIES
    Inventors: GERALYN DUSKA-MCEWEN, SARAH COMSTOCK, SHARON DONOVAN, RACHAEL BUCK, JOSEPH SCHALLER